307 related articles for article (PubMed ID: 18047508)
1. Confirmed cancer trends in families of patients with multiple cancers including cutaneous melanoma.
Nielsen K; Masback A; Bladstrom A; Lundgren L; Jonsson N; Borg A; Ingvar C; Olsson H
Br J Dermatol; 2008 Feb; 158(2):429-31. PubMed ID: 18047508
[No Abstract] [Full Text] [Related]
2. Familial melanoma and pancreatic cancer.
Bergman W; Gruis N
N Engl J Med; 1996 Feb; 334(7):471-2. PubMed ID: 8552160
[No Abstract] [Full Text] [Related]
3. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
[TBL] [Abstract][Full Text] [Related]
4. Primary breast and colon cancer associated with endometrial or ovarian cancer.
Auranen SA; Grénman SK; Mäkinen JI; Salmi TA
Ann Chir Gynaecol Suppl; 1994; 208():5-9. PubMed ID: 8092772
[TBL] [Abstract][Full Text] [Related]
5. Management of familial melanoma and nonmelanoma skin cancer syndromes.
Santillan AA; Cherpelis BS; Glass LF; Sondak VK
Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
[TBL] [Abstract][Full Text] [Related]
6. Familial melanoma and pancreatic cancer.
Wright FA; Thomas RG
N Engl J Med; 1996 Feb; 334(7):470-1; author reply 471-2. PubMed ID: 8552159
[No Abstract] [Full Text] [Related]
7. Re: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
Plna K; Hemminki K
J Natl Cancer Inst; 2001 Feb; 93(4):323-5. PubMed ID: 11181786
[No Abstract] [Full Text] [Related]
8. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer and melanoma in the same pedigree.
Seltzer MH; Leachman SA
Dermatol Online J; 2008 Nov; 14(11):1. PubMed ID: 19094839
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma.
Majore S; De Simone P; Crisi A; Eibenschutz L; Binni F; Antigoni I; De Bernardo C; Catricalà C; Grammatico P
Pigment Cell Melanoma Res; 2008 Apr; 21(2):209-11. PubMed ID: 18363633
[No Abstract] [Full Text] [Related]
11. Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland.
Debniak T; van de Wetering T; Scott R; Nagay L; Cybulski C; Górski B; Jakubowska A; Gronwald J; Masojć B; Huzarski T; Byrski T; Nej-Wołosiak K; Kładny J; Maleszka R; Lubinski J
Eur J Cancer Prev; 2008 Oct; 17(5):389-91. PubMed ID: 18714178
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
Goldstein AM; Fraser MC; Struewing JP; Hussussian CJ; Ranade K; Zametkin DP; Fontaine LS; Organic SM; Dracopoli NC; Clark WH
N Engl J Med; 1995 Oct; 333(15):970-4. PubMed ID: 7666916
[TBL] [Abstract][Full Text] [Related]
13. Melanoma genetics: an update on risk-associated genes.
Udayakumar D; Tsao H
Hematol Oncol Clin North Am; 2009 Jun; 23(3):415-29, vii. PubMed ID: 19464594
[TBL] [Abstract][Full Text] [Related]
14. Clinical genetic testing for familial melanoma in Italy: a cooperative study.
Bruno W; Ghiorzo P; Battistuzzi L; Ascierto PA; Barile M; Gargiulo S; Gensini F; Gliori S; Guida M; Lombardo M; Manoukian S; Menin C; Nasti S; Origone P; Pasini B; Pastorino L; Peissel B; Pizzichetta MA; Queirolo P; Rodolfo M; Romanini A; Scaini MC; Testori A; Tibiletti MG; Turchetti D; Leachman SA; Bianchi Scarrà G;
J Am Acad Dermatol; 2009 Nov; 61(5):775-82. PubMed ID: 19500876
[TBL] [Abstract][Full Text] [Related]
15. Familial melanoma and pancreatic cancer. Ligurian Skin Tumor Study Group.
Ciotti P; Strigini P; Bianchi-Scarrà G
N Engl J Med; 1996 Feb; 334(7):469-70; author reply 471-2. PubMed ID: 8552158
[No Abstract] [Full Text] [Related]
16. Genetic testing in familial melanoma: uptake and implications.
de Snoo FA; Riedijk SR; van Mil AM; Bergman W; ter Huurne JA; Timman R; Bertina W; Gruis NA; Vasen HF; van Haeringen A; Breuning MH; Tibben A
Psychooncology; 2008 Aug; 17(8):790-6. PubMed ID: 18613292
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
Berwick M; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Busam K; From L; Mujumdar U; Wilcox H; Begg CB;
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1520-5. PubMed ID: 16896043
[TBL] [Abstract][Full Text] [Related]
18. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.
Whelan AJ; Bartsch D; Goodfellow PJ
N Engl J Med; 1995 Oct; 333(15):975-7. PubMed ID: 7666917
[No Abstract] [Full Text] [Related]
19. Possible association between malignant melanoma and breast cancer.
Koh HK; Sober AJ; Carey RA
Arch Dermatol; 1987 Jun; 123(6):712-3. PubMed ID: 3579352
[No Abstract] [Full Text] [Related]
20. [MITF: a genetic key to melanoma and renal cell carcinoma?].
Bertolotto C; Lesueur F; Bressac de Paillerets B
Med Sci (Paris); 2012 Mar; 28(3):258-61. PubMed ID: 22480646
[No Abstract] [Full Text] [Related]
[Next] [New Search]
